芬兰莫比迪阿格（Mobidiag）
Mobidiag是一家设在芬兰首都赫尔辛基高科技公司，该公司针对脓毒症、肺炎和脑膜炎等常见传染病开发独有的生物芯片化验法，除病原体外，该公司还开发利用生物芯片技术确定抗生素生物标志的方法。从长远看，Mobidiag将专注于提供快速护理点(POC)解决方案，以诊断发病率很高的门诊疾病，例如，如呼吸和泌尿系统传染病。

Mobidiag Ltd, founded in 2001, is a Finnish biotech company specializing in rapid diagnostics of infectious diseases.

Our mission is to improve the quality of healthcare and to fight antimicrobial resistance by bringing the cutting-edge molecular diagnostic methods to the mainstream healthcare.

We develop and provide unique and innovative microarray-based Prove-it™ technology for early and accurate diagnosis of life-threatening pathogenic microbes causing severe infections.

Our core competency is the development of reliable diagnostic assays by combining the know-how of clinical questioning and assay content design with world leading platform and software technologies. This unique approach results improved diagnostic processes and increased customer value.

Our central location within the medical campus of the University of Helsinki, as well as contacts with leading international hospitals, provide us direct everyday contacts with the customers. This enables us to design and develop assays that meet customer requirements, and validate their performance in the clinical environment.